Space health breakthrough? bedrest study tests exercise and centrifuge combo
NCT ID NCT06544213
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study puts 24 healthy men on 60 days of strict bedrest to mimic weightlessness in space. Researchers are testing whether a special cycling exercise combined with artificial gravity from a centrifuge can prevent the body from weakening. The goal is to find better ways to keep astronauts healthy on long missions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward effective countermeasures for astronauts to maintain health during long space missions.
- What could go wrong
- This is a small, early-phase study in healthy men only, so results may not apply to women or people with medical conditions. The bedrest model only simulates some effects of weightlessness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
24 people
The number who actually took part.
- Started
-
Feb 2023
- Finished
-
Jun 2026
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 45 years
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy male volunteer (see below the description of medical tests and laboratory analysis performed at the selection visit) * Aged 20 to 45 years * No overweight nor excessive thinness with BMI (weight kg/ height m2) between 20 and 27 kg/m2 * Height between 158 and 190 cm * Certified as healthy by a comprehensive clinical assessment (detailed medical history and complete physical examination): in particular, free from any chronic disease or any acute infectious disease or cardiovascular, neurological, of the ear, nose, throat (especially orthostatic hypotension and vestibular disorders), orthopaedic or musculoskeletal disorders * Good mental health: tests and psychological interview will be held by a specialist in extreme environment * Fitness level assessment: 35 mL/min/kg \< VO2max \< 55 mL/min/kg * Non active smokers * No alcohol or drug dependence, and no medical treatment * Covered by a Health Insurance System * Having signed the information consent * Free of any engagement during the study Exclusion Criteria: * Any history or presence of clinically relevant cardiovascular, neurological or ear, nose, throat disease, any chronic disease; any acute infectious disease. Particularly: * Symptomatic orthostatic hypotension whatever the decrease in blood pressure, or asymptomatic postural hypotension defined by a decrease in systolic blood pressure equal to or greater than 20 mmHg within 3 minutes when changing from the supine to the standing position, * Cardiac rhythm disorders, * Hypertension, * Chronic back pains, * Vertebral fracture, scoliosis, or herniated disc, * Glaucoma, * Self-reported hearing problems, * Vestibular disorders * History of migraines, * History of hiatus hernia or gastro-esophageal reflux, * History of thyroid dysfunction, renal stones, diabetes, * History of head trauma, * Abnormal result for lower limbs echo-doppler, * History of genetic muscle and bone diseases of any kind, * Past records of thrombophlebitis, family history of thrombosis or positive response in thrombosis screening procedure (anti thrombin III, S-protein, C-protein, factor V Leiden mutation and the mutation 20210 of the prothrombin gene), * Bone mineral density: T-score ≤ -1.5, * Poor tolerance to blood sampling, * Having given whole blood (more than 7 mL/kg) in a period of 8 weeks or less before the start of the experiment, or having given whole blood more than 2 times in the past year, * Significant history of allergy, especially no dermatological or food allergy, * Significant anomaly detected in the biological analysis, * Positive reaction to any of the following tests: hepatitis A immunoglobulin, hepatitis B antigen, anti hepatitis C antibodies, anti Human Immunodeficiency Virus 1+2 antibodies, * Vegetarian or vegan, * Refusal to give permission to contact his general practitioner, * Subject who, in the judgment of the investigator, is likely to be non-compliant during the study, or unable to cooperate because of a language problem or poor mental development, * Subject already participating or in the exclusion period of a clinical research, * Subject who has received more than 4500 Euros within 12 months for being a research subject, * Subject who cannot be contacted in case of emergency, * Subject who had the two knees injured * MRI contraindications * History or active claustrophobia * Osteosynthesis material, presence of metallic implants or any other contra-indication for MRI * Vulnerable persons according to French law (L1121-5 to L1121-8) : * Persons deprived of their liberty by an administrative or judicial decision * Persons under involuntary psychiatric care * Persons admitted in a health or social establishment for purposes other than research * Minors * Adults subject to legal protection (subject under guardianship or trusteeship) or unable to express their consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Simulated microgravity by head Down tilt bedrest are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MEDES-Institut de Médecine et Physiologie Spatiale
Toulouse, France, 31400, France